Structure Therapeutics is trading 4.5% up at $36.57, moving higher alongside a strong September 21, 2026 equity rally.

  • The S&P 500 was up 0.99%, while the Nasdaq Composite gained 1.57%.
  • Declining oil prices and Treasury yields supported risk appetite.
  • No fresh company-specific announcement was identified; recent obesity-pipeline updates remain supportive background, but evidence points primarily to broad market sentiment rather than a new corporate catalyst.